In accordance with the previous study, our study also showed that homoharringtonine synergized with venetoclax to deeply inhibit MCL1 and BCL-XL, and VAH increased the activation of BAX in AML cell lines (Additional file 1: Fig. S1). This evidence concerns the gene BCL2L1 and acute myeloid leukemia.